Cancer prevention through supplements
Adjunct
Trametes versicolor (PSK, Krestin) is the only medicinal mushroom with relatively convincing evidence as chemotherapy adjuvant. Fritz 2015 (Integr Cancer Ther) systematic review of 5 RCTs in 1094 lung cancer patients: PSK added to standard chemotherapy improved 5-year survival by 9% vs chemotherapy alone. In Japan PSK has been approved since 1977 as adjuvant in gastric cancer after radical surgery. ESMO 2024 for gastric cancer lists FLOT or CapeOX/SOX first-line adjuvant, platinum doublets with trastuzumab (HER2+) or nivolumab (PD-L1+) in metastatic disease; PSK is not in European international guidelines and remains in Japanese practice. As monotherapy supplement does not replace standard treatment; used only in combination under oncology supervision. AEMPS does not register turkey tail as medicine.